ATE451469T1 - In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten - Google Patents

In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten

Info

Publication number
ATE451469T1
ATE451469T1 AT99950860T AT99950860T ATE451469T1 AT E451469 T1 ATE451469 T1 AT E451469T1 AT 99950860 T AT99950860 T AT 99950860T AT 99950860 T AT99950860 T AT 99950860T AT E451469 T1 ATE451469 T1 AT E451469T1
Authority
AT
Austria
Prior art keywords
bacterial
yeast cells
amino acid
protein
amino acids
Prior art date
Application number
AT99950860T
Other languages
English (en)
Inventor
Philippe Marliere
Volker Doering
Henning Mootz
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE451469T1 publication Critical patent/ATE451469T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Ecology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
AT99950860T 1998-10-28 1999-10-28 In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten ATE451469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9813533A FR2785291B1 (fr) 1998-10-28 1998-10-28 Procede de production in vivo de proteines chimiquement diversifiees par incorporation d'acides amines non conventionnels
PCT/FR1999/002628 WO2000024922A1 (fr) 1998-10-28 1999-10-28 Procede de production in vivo de proteines chimiquement diversifiees par incorporation d'acides amines non conventionnels

Publications (1)

Publication Number Publication Date
ATE451469T1 true ATE451469T1 (de) 2009-12-15

Family

ID=9532101

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99950860T ATE451469T1 (de) 1998-10-28 1999-10-28 In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten

Country Status (10)

Country Link
US (1) US7736899B1 (de)
EP (1) EP1124983B1 (de)
JP (1) JP4427902B2 (de)
AT (1) ATE451469T1 (de)
AU (1) AU769879B2 (de)
CA (1) CA2347993A1 (de)
DE (1) DE69941789D1 (de)
FR (1) FR2785291B1 (de)
NZ (1) NZ511932A (de)
WO (1) WO2000024922A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808284B1 (fr) * 2000-04-28 2004-11-19 Pasteur Institut Souches mutantes capables de produire des proteines chimiquement diversifiees par incorporation d'acides amines non conventionnels
DE60215881T2 (de) 2001-04-19 2007-06-14 Institut Pasteur Methode für die Erweiterung der chemischen Zusammensetzung von Proteinen produziert in vivo unter Verwendung von mutierten Aminoacyl-tRNA-Synthetasen ohne Korrekturfunktion
EP1251175B1 (de) * 2001-04-19 2006-11-08 Institut Pasteur Methode für die Erweiterung der chemischen Zusammensetzung von Proteinen produziert in vivo unter Verwendung von mutierten Aminoacyl-tRNA-Synthetasen ohne Korrekturfunktion
US20040214314A1 (en) 2001-11-02 2004-10-28 Friedrich Srienc High throughput bioreactor
US7288382B2 (en) 2002-03-14 2007-10-30 The Board Of Trustees Od The Leland Stanford Junior University Methods for structural analysis of proteins
WO2012027533A1 (en) * 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods

Also Published As

Publication number Publication date
EP1124983B1 (de) 2009-12-09
CA2347993A1 (fr) 2000-05-04
WO2000024922A1 (fr) 2000-05-04
DE69941789D1 (de) 2010-01-21
AU769879B2 (en) 2004-02-05
US7736899B1 (en) 2010-06-15
JP2002528090A (ja) 2002-09-03
AU6347399A (en) 2000-05-15
JP4427902B2 (ja) 2010-03-10
FR2785291A1 (fr) 2000-05-05
EP1124983A1 (de) 2001-08-22
NZ511932A (en) 2004-02-27
FR2785291B1 (fr) 2003-03-07

Similar Documents

Publication Publication Date Title
ATE414782T1 (de) Verfahren zur herstellung von polypeptiden in mutierten aspergillus zellen
DE69720026T2 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
ATE246251T1 (de) Verfahren zur herstellung von polypeptiden in surfaktinmutanten von bacillus zellen
ES8700320A1 (es) Metodo de obtencion del exprimido de una materia seleccionada que contiene renina.
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DE69333145D1 (de) Methode zur kontrollierten herstellung von polypeptiden in bakterien
DE60120619D1 (de) Verfahren zur Herstellung einer Zielsubstanz durch Fermentation
KR840002031A (ko) Dna, 재조합 dna, 이들을 갖는 숙주 및 폴리펩타이드를 제조하는 방법
ATE353953T1 (de) Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
ATE429492T1 (de) Dna-kette zur erhöhung der produktion von karotenoiden
ATE395424T1 (de) Verfahren zur herstellung von heterologen polypeptiden in trichothecene mangelmutanten filamentlösen pilzen
AU9086398A (en) G protein chimeras
EP2298911A3 (de) Verfahren zur Herstellung von Polypeptiden in atmungsdefizienten Zellen
ATE451469T1 (de) In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten
RU2218405C2 (ru) Белок, обладающий активностью d-пантолактонгидролазы, нуклеиновая кислота, его кодирующая, вектор, штамм, способ получения белка, способ получения d-пантолактона
ATE465259T1 (de) Für das dapc-gen kodierende nukleotidsequenzen und verfahren zur herstellung von l-lysin
JPS60500043A (ja) 原核細胞又は真核細胞中で合成される融合蛋白質から成熟蛋白質を作る方法
DE60312592D1 (de) Verfahren zur Herstellung von L-Lysin unter Verwendung Coryneformer Bakterien die ein attenuiertes Malat Enzym-gen enthalten
DE69425809D1 (de) Methoden zur Herstellung von Protein C
US5190875A (en) Peptide amidase and the use thereof
DE10114999A1 (de) D-Carbamoylase aus Arthrobacter crystallopoietes DSM 20117
CA2226287A1 (en) Novel secretion factors for gram-positive microorganisms, genes encoding them and methods of using it
EP1262551A3 (de) Sorbitol-Dehydrogenase Gen, rekombinante DNA, und Verfahren zur Herstellung von Sorbitol-Dehydrogenase
KR20030006724A (ko) 신규한 ｄ-입체특이적 아미노산 아미다아제, 그의 유전자,그의 제조방법, 이를 이용한 ｄ-아미노산의 제조방법
ATE312195T1 (de) Verfahren zur herstellung von fremden proteinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1124983

Country of ref document: EP